跳至主要内容
临床试验/CTRI/2019/02/017458
CTRI/2019/02/017458已完成3 期

An Open label Non-randomized Single arm clinical study to evaluate efficacy of Somvalkal Kashay Siddha Basti in Prameha

Dr Nakul Khode0 个研究点目标入组 31 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
31

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with symptoms of Prameha as per Ayurvedic classics and Type 2 diabetes mellitus as per modern medicine
  • Age group between 30 to 60 years
  • HbA1c value will 6.5 percentage or above
  • Patients taking Biguanides group anti-diabetic drugs
  • Fasting blood sugar level within 150 mgdl and Post prandial blood sugar within 250 mgdl

排除标准

  • HbA1c values will less than 6.5 percentage
  • Patients taking other than Biguanides group anti diabetic drugs
  • Patients of Insulin dependent diabetes mellitus
  • Diabetes due to Endocrinopathies for eg Pheochromocytoma Acromegaly Cushing syndrome
  • Drugs or chemical induced diabetes mellitus eg Glucocorticoids thyroid hormone Thiazide Phenytoin etc
  • Patients with other systemic complication like cardiovascular nephropathic diseases etc
  • Basti Anarha

研究者

发起方
Dr Nakul Khode

相似试验